Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Timothy Hoey Insider Profile
4 Followers
Timothy Hoey, SVP, Cancer Biology at OncoMed Pharma, holds 47.18K shares in OncoMed Pharma (Ticker: OMED).
Timothy Hoey OncoMed Pharma (OMED)SVP, Cancer Biology
OncoMed Pharma (OMED)
SVP, Cancer Biology
Not Ranked
Timothy Hoey has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Timothy Hoey does not currently own shares as a corporate insider.
A breakdown of Timothy Hoey's holdings
Insider Roles
Timothy Hoey does not currently hold a role as a corporate insider.
Roles that Timothy Hoey holds in companies
Most Profitable Insider Trade
Stock:
OncoMed Pharma
(OMED)
(OMED)
Rating:Informative Sell
Date:Jan 08, 2016 - Jan 08, 2017
Return:+57.80%
The most profitable trade made by Timothy Hoey
Timothy Hoey's Trading History
List of latest transactions for each holding click on a transaction to see Timothy Hoey's performance on stock
You May Also Like
Timothy Hoey insider profile FAQ
What is the percentage of profitable transactions made by Timothy Hoey?
The percentage of profitable transactions made by Timothy Hoey is ―.
What is the average return per transaction made by Timothy Hoey?
The average return per transaction made by Timothy Hoey is ―.
What stocks does Timothy Hoey hold?
Timothy Hoey holds: OMED stocks.
What was Timothy Hoey’s latest transaction?
Timothy Hoey latest transaction was an Uninformative Buy of ―.
What was Timothy Hoey's most profitable transaction?
Timothy Hoey’s most profitable transaction was an Informative Sell of OMED stock on January 8, 2016. The return on the trade was 57.80%.
What is Timothy Hoey's role in OncoMed Pharma?
Timothy Hoey's role in OncoMed Pharma is SVP, Cancer Biology.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.